| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 18.159 | 30.003 | 62.766 | 98.812 | 154.024 | 169.755 | 180.739 | 213.290 | 222.972 |
| Total Income - EUR | - | 18.159 | 30.003 | 62.767 | 98.813 | 154.026 | 169.758 | 180.742 | 213.292 | 223.353 |
| Total Expenses - EUR | - | 7.407 | 18.197 | 46.412 | 78.699 | 118.469 | 125.917 | 138.084 | 141.258 | 159.873 |
| Gross Profit/Loss - EUR | - | 10.752 | 11.806 | 16.355 | 20.115 | 35.557 | 43.841 | 42.658 | 72.034 | 63.479 |
| Net Profit/Loss - EUR | - | 10.207 | 11.506 | 15.728 | 19.127 | 34.134 | 42.143 | 40.887 | 70.222 | 56.913 |
| Employees | - | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dumitras Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 114 | 569 | 1.774 | 72.227 | 56.162 | 55.043 | 30.203 | 15.646 | 16.934 |
| Current Assets | - | 10.532 | 11.553 | 16.781 | 22.636 | 48.409 | 97.276 | 50.773 | 119.351 | 48.605 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.296 | 3.447 | 5.290 | 10.550 | 12.762 | 20.020 | 15.507 | 43.499 | 20.504 |
| Cash | - | 8.236 | 8.106 | 11.491 | 12.086 | 35.647 | 77.257 | 35.267 | 75.852 | 28.101 |
| Shareholders Funds | - | 10.251 | 11.559 | 15.780 | 19.177 | 52.948 | 93.916 | 40.935 | 111.033 | 56.961 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 394 | 1.013 | 2.853 | 75.789 | 51.787 | 59.152 | 40.820 | 27.106 | 11.551 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dumitras Med Srl